These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 7227939)

  • 1. [Clinical aspects and chemotherapy of adenocarcinoma of the kidney].
    Possinger K; Hartenstein R; Ehrhart H
    Fortschr Med; 1981 Mar; 99(12):419-23. PubMed ID: 7227939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic therapy of metastatic renal cell carcinoma.
    Vugrin D
    Semin Nephrol; 1987 Jun; 7(2):152-62. PubMed ID: 2442806
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of metastatic renal cell carcinoma: review of experience and world literature.
    Luderer RC; Opipari MI; Perrotta AL
    J Am Osteopath Assoc; 1978 Apr; 77(8):590-603. PubMed ID: 649445
    [No Abstract]   [Full Text] [Related]  

  • 4. Current status of chemotherapy, hormonal therapy, and immunotherapy in the treatment of renal cell carcinoma.
    Poster DS; Bruno S; Penta JS; Pinna K; Vilk P; Macdonald JS
    Am J Clin Oncol; 1982 Feb; 5(1):53-60. PubMed ID: 7081138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-agent therapy for renal cell carcinoma: CCNU, vinblastine, thioTEPA, or bleomycin.
    Hahn DM; Schimpff SC; Ruckdeschel JC; Wiernik PH
    Cancer Treat Rep; 1977 Nov; 61(8):1585-7. PubMed ID: 72603
    [No Abstract]   [Full Text] [Related]  

  • 6. Testing of chemotherapeutic agents in murine renal cell adenocarcinoma.
    Murphy GP; Williams PD
    Res Commun Chem Pathol Pharmacol; 1974 Oct; 9(2):265-77. PubMed ID: 4438832
    [No Abstract]   [Full Text] [Related]  

  • 7. Renal cell carcinoma: analysis of 31 cases with assessment of endocrine therapy.
    Papac RJ; Ross SA; Levy A
    Am J Med Sci; 1977; 274(3):281-90. PubMed ID: 610416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of vinblastine resistance in metastatic renal cell carcinoma with cyclosporine A or tamoxifen: a cancer and leukemia group B study.
    Samuels BL; Hollis DR; Rosner GL; Trump DL; Shapiro CL; Vogelzang NJ; Schilsky RL
    Clin Cancer Res; 1997 Nov; 3(11):1977-84. PubMed ID: 9815587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The management of metastatic renal cell carcinoma.
    Peterson LJ
    Compr Ther; 1977 Feb; 3(2):20-4. PubMed ID: 837655
    [No Abstract]   [Full Text] [Related]  

  • 10. Chemotherapy for renal cell carcinoma.
    Hartmann JT; Bokemeyer C
    Anticancer Res; 1999; 19(2C):1541-3. PubMed ID: 10365141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II study of vinblastine-CCNU, triazinate, and dactinomycin in advanced renal cell cancer.
    Hahn RG; Begg CB; Davis T
    Cancer Treat Rep; 1981; 65(7-8):711-13. PubMed ID: 7018680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hormonal therapy and chemotherapy of renal-cell carcinoma.
    Harris DT
    Semin Oncol; 1983 Dec; 10(4):422-30. PubMed ID: 6320451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II trial of combination methyl-GAG and vinblastine in the treatment of metastatic renal adenocarcinoma.
    Todd RF; Garnick MB; Canellos GP
    Cancer Treat Rep; 1982 Jul; 66(7):1585-6. PubMed ID: 7093973
    [No Abstract]   [Full Text] [Related]  

  • 14. Chemotherapy for renal cell carcinoma.
    Amato RJ
    Semin Oncol; 2000 Apr; 27(2):177-86. PubMed ID: 10768596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soft agar clonogenic assay for primary human renal carcinoma: in vitro chemotherapeutic drug sensitivity testing.
    Lieber MM; Kovach JS
    Invest Urol; 1981 Sep; 19(2):111-4. PubMed ID: 7275551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [the oral use of a progestational hormone (Provera 100) as an adjuvant in therapy of adenocarcinoma of the kidney. Preliminary report].
    Liberti M; Di Silverio F; Concolino G; Tenaglia R; Marocchi A
    Minerva Urol; 1980; 32(3):175-8. PubMed ID: 7432332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination of vinblastine and bleomycin in metastatic renal cell carcinoma.
    Knost JA; Oldham RK; Hande KR; Rhamy RK; Greco FA
    Cancer Treat Rep; 1981; 65(3-4):349-50. PubMed ID: 6165469
    [No Abstract]   [Full Text] [Related]  

  • 18. Bilateral leiomyosarcoma of the kidney with family history of kidney cancer.
    Kadikoy H; Haque WM; Topkara VK; Frome AI; Hayes TG
    Can J Urol; 2009 Oct; 16(5):4847-9. PubMed ID: 19796464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current status of the therapy of advanced renal carcinoma.
    Hrushesky WJ; Murphy GP
    J Surg Oncol; 1977; 9(3):277-88. PubMed ID: 327158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Palliative treatment of metastasized hypernephroma].
    Klippel KF; Altwein JE
    Dtsch Med Wochenschr; 1979 Jan; 104(1):28-31. PubMed ID: 83228
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.